123 related articles for article (PubMed ID: 16154916)
1. Pyrexia, anorexia, adipsia, and depressed motor activity in rats during systemic inflammation induced by the Toll-like receptors-2 and -6 agonists MALP-2 and FSL-1.
Hübschle T; Mütze J; Mühlradt PF; Korte S; Gerstberger R; Roth J
Am J Physiol Regul Integr Comp Physiol; 2006 Jan; 290(1):R180-7. PubMed ID: 16154916
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-activating lipopeptide-2 (MALP-2) induces a localized inflammatory response in rats resulting in activation of brain sites implicated in fever.
Knorr C; Hübschle T; Murgott J; Mühlradt P; Gerstberger R; Roth J
Brain Res; 2008 Apr; 1205():36-46. PubMed ID: 18353287
[TBL] [Abstract][Full Text] [Related]
3. Effects of repeated injections of fibroblast-stimulating lipopeptide-1 on fever, formation of cytokines, and on the responsiveness to endotoxin in guinea-pigs.
Greis A; Murgott J; Gerstberger R; Hübschle T; Roth J
Acta Physiol (Oxf); 2009 Sep; 197(1):35-45. PubMed ID: 19309391
[TBL] [Abstract][Full Text] [Related]
4. Relationship between structures and biological activities of mycoplasmal diacylated lipopeptides and their recognition by toll-like receptors 2 and 6.
Okusawa T; Fujita M; Nakamura J; Into T; Yasuda M; Yoshimura A; Hara Y; Hasebe A; Golenbock DT; Morita M; Kuroki Y; Ogawa T; Shibata K
Infect Immun; 2004 Mar; 72(3):1657-65. PubMed ID: 14977973
[TBL] [Abstract][Full Text] [Related]
5. Fever induction by systemic stimulation with macrophage-activating lipopeptide-2 depends upon TLR2 but not CD36.
Welsch J; Hübschle T; Murgott J; Kirschning C; Rummel C; Gerstberger R; Roth J
Innate Immun; 2012 Jun; 18(3):541-59. PubMed ID: 22042912
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the febrile response induced by fibroblast-stimulating lipopeptide-1 in guinea pigs.
Greis A; Murgott J; Rafalzik S; Gerstberger R; Hübschle T; Roth J
Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R152-61. PubMed ID: 17491112
[TBL] [Abstract][Full Text] [Related]
7. Peripheral and central cyclooxygenase (COX) products may contribute to the manifestation of brain-controlled sickness responses during localized inflammation induced by macrophage-activating lipopeptide-2 (MALP-2).
Knorr C; Marks D; Gerstberger R; Mühlradt PF; Roth J; Rummel C
Neurosci Lett; 2010 Jul; 479(2):107-11. PubMed ID: 20580659
[TBL] [Abstract][Full Text] [Related]
8. The Toll-Like Receptor 2/6 Agonist, FSL-1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome.
Kurkjian CJ; Guo H; Montgomery ND; Cheng N; Yuan H; Merrill JR; Sempowski GD; Brickey WJ; Ting JP
Sci Rep; 2017 Dec; 7(1):17355. PubMed ID: 29230065
[TBL] [Abstract][Full Text] [Related]
9. Mycoplasma fermentans and TNF-beta interact to amplify immune-modulating cytokines in human lung fibroblasts.
Fabisiak JP; Gao F; Thomson RG; Strieter RM; Watkins SC; Dauber JH
Am J Physiol Lung Cell Mol Physiol; 2006 Oct; 291(4):L781-93. PubMed ID: 16751226
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptor 2 and 6 agonist fibroblast-stimulating lipopeptide increases expression and secretion of CXCL1 and CXCL2 by uveal melanocytes.
Hu DN; Zhang R; Iacob CE; Yao S; Yang SF; Chan CC; Rosen RB
Exp Eye Res; 2022 Mar; 216():108943. PubMed ID: 35074346
[TBL] [Abstract][Full Text] [Related]
11. Synthetic mycoplasma-derived lipopeptide MALP-2 induces maturation and function of dendritic cells.
Weigt H; Mühlradt PF; Emmendörffer A; Krug N; Braun A
Immunobiology; 2003; 207(3):223-33. PubMed ID: 12777064
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 2/6 agonist macrophage-activating lipopeptide-2 promotes reendothelialization and inhibits neointima formation after vascular injury.
Grote K; Sonnenschein K; Kapopara PR; Hillmer A; Grothusen C; Salguero G; Kotlarz D; Schuett H; Bavendiek U; Schieffer B
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2097-104. PubMed ID: 23868938
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effects of TLR-2/6 ligation in pulmonary bacterial infection and immunization with Pseudomonas aeruginosa.
Kerber-Momot T; Leemhuis D; Lührmann A; Munder A; Tümmler B; Pabst R; Tschernig T
Inflammation; 2010 Feb; 33(1):58-64. PubMed ID: 19844782
[TBL] [Abstract][Full Text] [Related]
14. Dissociation between learning and memory impairment and other sickness behaviours during simulated Mycoplasma infection in rats.
Swanepoel T; Harvey BH; Harden LM; Laburn HP; Mitchell D
Brain Behav Immun; 2011 Nov; 25(8):1607-16. PubMed ID: 21635947
[TBL] [Abstract][Full Text] [Related]
15. Local pulmonary immune stimulation by the Toll-like receptor 2 and 6 ligand MALP-2 in rats is age dependent.
Lührmann A; Grote K; Stephan M; Tschernig T; Pabst R
Immunol Lett; 2007 Feb; 108(2):167-73. PubMed ID: 17275100
[TBL] [Abstract][Full Text] [Related]
16. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
Takeuchi O; Kaufmann A; Grote K; Kawai T; Hoshino K; Morr M; Mühlradt PF; Akira S
J Immunol; 2000 Jan; 164(2):554-7. PubMed ID: 10623793
[TBL] [Abstract][Full Text] [Related]
17. Intratumoural injection of the toll-like receptor-2/6 agonist 'macrophage-activating lipopeptide-2' in patients with pancreatic carcinoma: a phase I/II trial.
Schmidt J; Welsch T; Jäger D; Mühlradt PF; Büchler MW; Märten A
Br J Cancer; 2007 Sep; 97(5):598-604. PubMed ID: 17667928
[TBL] [Abstract][Full Text] [Related]
18. FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection.
Rose WA; McGowin CL; Pyles RB
Virol J; 2009 Nov; 6():195. PubMed ID: 19903337
[TBL] [Abstract][Full Text] [Related]
19. Simulated acute central Mycoplasma infections in rats induce fever, anorexia, body mass stunting and lethargy but spare memory.
Swanepoel T; Sabbar M; Baartman TL; Laburn HP; Mitchell D; Dukhan T; Harden LM
Physiol Behav; 2016 Sep; 163():294-304. PubMed ID: 27180133
[TBL] [Abstract][Full Text] [Related]
20. A new cell-based innate immune receptor assay for the examination of receptor activity, ligand specificity, signalling pathways and the detection of pyrogens.
Burger-Kentischer A; Abele IS; Finkelmeier D; Wiesmüller KH; Rupp S
J Immunol Methods; 2010 Jun; 358(1-2):93-103. PubMed ID: 20385141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
